Mesoblast Limited Presents Positive Adult Stem Cell Results To American Academy Of Orthopedic Surgeons (AAOS)
Mesoblast Limited (ASX:MSB)(PINK:MBLTY) Australia’s regenerative medicine company today announced that three separate papers disclosing clinical and preclinical trial results were presented this week to orthopaedic specialists attending the 55th annual meeting of the American Academy of Orthopedic Surgeons (AAOS) and the Orthopedic Research Society (ORS). The meetings, underway in Las Vegas, attract an estimated 15,000 orthopedic healthcare professionals from around the world.
[Read the full article here]Related News:
Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell …
EHSI: New Stem Cell Treatment Could Help Cure Diabetes
Tengion Presents New Data Supporting its Organ Regeneration Platform at 8th Annual Meeting of the International Society for Stem Cell Research